Literature DB >> 16953416

More pronounced salt dependence and higher reactivity for platination of the hairpin r(CGCGUUGUUCGCG) compared with d(CGCGTTGTTCGCG).

Margareta Hägerlöf1, Pal Papsai, Christine S Chow, Sofi K C Elmroth.   

Abstract

The DNA interference pathways exhibited by cisplatin and related anticancer active metal complexes have been extensively studied. Much less is known to what extent RNA interaction pathways may operate in parallel, and perhaps contribute to both antineoplastic activity and toxicity. The present study was designed with the aim of comparing the reactivity of two model systems comprising RNA and DNA hairpins, r(CGCGUUGUUCGCG) and d(CGCGTTGTTCGCG), towards a series of platinum(II) complexes. Three platinum complexes were used as metallation reagents; cis-[PtCl(NH3)2(OH2)]+ (1), cis-[PtCl(NH3)(c-C6H11NH2)(OH2)]+ (2), and trans-[PtCl(NH3)(quinoline)(OH2)]+ (3). The reaction kinetics were studied at pH 6.0, 25 degrees C, and 1.0 mM < or = I < or = 500 mM. For both types of nucleic acid targets, compound 3 was found to react about 1 order of magnitude more rapidly than compounds 1 and 2. Further, all platinum compounds exhibited a more pronounced salt dependence for the interaction with r(CGCGUUGUUCGCG). Chemical and enzymatic cleavage studies revealed similar interaction patterns with r(CGCGUUGUUCGCG) after long exposure times to 1 and 2. A substantial decrease of cleavage intensity was found at residues G4 and G7, indicative of bifunctional adduct formation. Circular dichroism studies showed that platinum adduct formation leads to a structural change of the ribonucleic acid. Thermal denaturation studies revealed platination to cause a decrease of the RNA melting temperatures by 5-10 degrees C. Our observations therefore suggest that RNA is a kinetically competitive target to DNA. Furthermore, platination causes destabilization of RNA structural elements, which may lead to deleterious intracellular effects on biologically relevant RNA targets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16953416     DOI: 10.1007/s00775-006-0157-y

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  73 in total

1.  Comparative anti-tumor efficacy of two orally administered platinum(IV) drugs in nude mice bearing human tumor xenografts.

Authors:  Petr Sova; Adolf Mistr; Ales Kroutil; Frantisek Zak; Pavla Pouckova; Marie Zadinova
Journal:  Anticancer Drugs       Date:  2006-02       Impact factor: 2.248

2.  Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).

Authors:  A Eastman
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

3.  Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.

Authors:  U M Ohndorf; M A Rould; Q He; C O Pabo; S J Lippard
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

4.  Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC).

Authors:  Tahir Latif; Laura Wood; Cindy Connell; David C Smith; David Vaughn; David Lebwohl; David Peereboom
Journal:  Invest New Drugs       Date:  2005-01       Impact factor: 3.850

5.  Medium Effects on Reactivity Profiles for Platination of Phosphorothioate-Containing Oligonucleotides.

Authors:  Johan Kjellström; Sofi K. C. Elmroth
Journal:  Inorg Chem       Date:  1999-12-27       Impact factor: 5.165

6.  Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes.

Authors:  D L Evans; C Dive
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

7.  Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.

Authors:  Frantisek Zák; Jaroslav Turánek; Ales Kroutil; Petr Sova; Adolf Mistr; Anna Poulová; Petr Mikolin; Zdirad Zák; Andrea Kasná; Dana Záluská; Jirí Neca; Lenka Sindlerová; Alois Kozubík
Journal:  J Med Chem       Date:  2004-01-29       Impact factor: 7.446

8.  DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].

Authors:  A Zákovská; O Nováková; Z Balcarová; U Bierbach; N Farrell; V Brabec
Journal:  Eur J Biochem       Date:  1998-06-15

9.  Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.

Authors:  Goli Samimi; Roohangiz Safaei; Kuniyuki Katano; Alison K Holzer; Myriam Rochdi; Mika Tomioka; Murray Goodman; Stephen B Howell
Journal:  Clin Cancer Res       Date:  2004-07-15       Impact factor: 12.531

10.  Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.

Authors:  L R Kelland; G Abel; M J McKeage; M Jones; P M Goddard; M Valenti; B A Murrer; K R Harrap
Journal:  Cancer Res       Date:  1993-06-01       Impact factor: 12.701

View more
  9 in total

Review 1.  Binding of kinetically inert metal ions to RNA: the case of platinum(II).

Authors:  Erich G Chapman; Alethia A Hostetter; Maire F Osborn; Amanda L Miller; Victoria J DeRose
Journal:  Met Ions Life Sci       Date:  2011

2.  Rapid cross-linking of an RNA internal loop by the anticancer drug cisplatin.

Authors:  Alethia A Hostetter; Erich G Chapman; Victoria J DeRose
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

3.  Cisplatin fastens chromatin irreversibly even at a high chloride concentration.

Authors:  Hyeon-Min Moon; Jin-Sung Park; Il-Buem Lee; Young-Im Kang; Hae Jun Jung; Dongju An; Yumi Shin; Min Ji Kim; Hugh I Kim; Ji-Joon Song; Jaehoon Kim; Nam-Kyung Lee; Seok-Cheol Hong
Journal:  Nucleic Acids Res       Date:  2021-12-02       Impact factor: 16.971

4.  Enzymatic processing of platinated RNAs.

Authors:  Erich G Chapman; Victoria J DeRose
Journal:  J Am Chem Soc       Date:  2010-02-17       Impact factor: 15.419

5.  Cisplatin and siRNA interference with structure and function of Wnt-5a mRNA: design and in vitro evaluation of targeting AU-rich elements in the 3' UTR.

Authors:  Margareta Hägerlöf; Pal Papsai; Hanna K Hedman; Ute Jungwirth; Veronika Jenei; Sofi K C Elmroth
Journal:  J Biol Inorg Chem       Date:  2007-12-06       Impact factor: 3.358

6.  DNA-Destabilizing Agents as an Alternative Approach for Targeting DNA: Mechanisms of Action and Cellular Consequences.

Authors:  Gaëlle Lenglet; Marie-Hélène David-Cordonnier
Journal:  J Nucleic Acids       Date:  2010-07-25

7.  Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins.

Authors:  Gayani N P Dedduwa-Mudalige; Christine S Chow
Journal:  Int J Mol Sci       Date:  2015-09-07       Impact factor: 5.923

8.  Amino acid-linked platinum(II) compounds: non-canonical nucleoside preferences and influence on glycosidic bond stabilities.

Authors:  Bett Kimutai; C C He; Andrew Roberts; Marcel L Jones; Xun Bao; Jun Jiang; Zhihua Yang; M T Rodgers; Christine S Chow
Journal:  J Biol Inorg Chem       Date:  2019-07-29       Impact factor: 3.358

Review 9.  Under-Reported Aspects of Platinum Drug Pharmacology.

Authors:  Dirk Theile
Journal:  Molecules       Date:  2017-02-28       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.